Abbreviations
- EGFr:
-
Epidermal growth factor receptor
- EIA:
-
Enzyme immunoassay
- ER:
-
Estrogen receptor
- TGFα:
-
Transforming growth factor #x03B1;
References
Prigent SA, Lemoine NR: The type 1 (EGFR-related) family of growth factor receptors and their ligands.Progress in Growth Factor Res 4:1–24, 1992.
Lippman ME, Dickson RB, Kasid A,et al: Autocrine and paracrine growth regulation of human breast cancer.J Steroid Biochem 24:147–154, 1986.
Di Marco E, Pierce JH, Fleming TP,et al: Autocrine interaction between TGFα and the EGF-receptor.Oncogene 4:831–838, 1989.
Umekita Y, Enokizono N, Sagara Y,et al: Immunohistochemical studies on oncogene products (EGF-R, c-erbB-2 and growth factors (EGF, TGFα) in human breast cancer; Their relationship to oestrogen receptor status, histological grade, mitotic index and nodal status.Virchows Arch A Pathol Anst 420:345- 351, 1992.
EORTC Breast Cancer Cooperative Group: Revision of the standars for the assessments of hormone receptors in human breast cancer.Eur J Cancer Clin Oncol 16:1513–1515, 1980.
Klijn JGM, Berns PMJJ, Schmitz PIM,et al: The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer; A review on 5232 patients.Endocrine Rev 13:3–17, 1992.
Tsuda H, Hirohashi S, Shimosato Y,et al: Immunohistochemical study on overexpression of c-erbB-2 protein in human breast cancer; Its correlation with gene amplification and long-term survival of patients.Jpn J Cancer Res 81:327–332, 1990.
Author information
Authors and Affiliations
About this article
Cite this article
Narita, T., Funahashi, H., Imai, T. et al. Correlation between the concentration of C-ERBB-2 protein, EGF-receptor and TGFα in breast cancer tissue, and clinicopathological parameters. Breast Cancer 1, 57–59 (1994). https://doi.org/10.1007/BF02967376
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02967376